Atlas Trials

Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma

Clinical trial NCT01889420 · TERMINATED

Trial details

NCT number
NCT01889420
Sponsor
New Mexico Cancer Research Alliance
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Multiple Myeloma in Relapse
Start date
2014-07-01
Primary completion
2015-06-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.